Cargando…
Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases
Emerging evidence reveals that various cytokines and tissue microenvironments contribute to liver inflammation and autoimmunity, and IL-17 family is one of highlights acknowledged. Although the implication of IL-17 family in most common autoimmune diseases (such as psoriasis, inflammatory bowel dise...
Autores principales: | Zhang, Haiyan, Bernuzzi, Francesca, Lleo, Ana, Ma, Xiong, Invernizzi, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471389/ https://www.ncbi.nlm.nih.gov/pubmed/26146463 http://dx.doi.org/10.1155/2015/436450 |
Ejemplares similares
-
The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics
por: Bianchi, Ilaria, et al.
Publicado: (2012) -
Management of patients with autoimmune liver disease during COVID-19 pandemic
por: Lleo, Ana, et al.
Publicado: (2020) -
IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis
por: Kurte, Mónica, et al.
Publicado: (2018) -
The risk of liver cancer in autoimmune liver diseases
por: Lleo, Ana, et al.
Publicado: (2019) -
IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP)
por: Murphy, Stephen F., et al.
Publicado: (2015)